Wacheck, V
28  Ergebnisse:
Personensuche X
?
2

Innovation in oncology clinical trial design:

Verweij, J. ; Hendriks, H.R. ; Zwierzina, H....
Cancer Treatment Reviews.  74 (2019)  - p. 15-20 , 2019
 
?
4

Differential role of circulating endothelial progenitor cel..:

Sieghart, W. ; Fellner, S. ; Reiberger, T....
Digestive and Liver Disease.  41 (2009)  12 - p. 902-906 , 2009
 
?
5

Differential role of circulating endothelial progenitor cel..:

Sieghart, W. ; Fellner, S. ; Reiberger, T....
Digestive and Liver Disease.  41 (2009)  12 - p. 902-906 , 2009
 
?
6

SPC2996 – a potent, specific, long-lived and safe inhibitor..:

Hedtjärn, M. ; Høg, A. Mølhart ; Frieden, M....
European Journal of Cancer Supplements.  6 (2008)  9 - p. 109 , 2008
 
?
7

A clinical trial on absorption and N‐acetylation of oral an..:

Dilger, K. ; Trenk, D. ; Rössle, M....
European Journal of Clinical Investigation.  37 (2007)  7 - p. 558-565 , 2007
 
?
8

P048 A CLINICAL TRIAL ON ABSORPTION AND N-ACETYLATION OF OR..:

Dilger, K. ; Trenk, D. ; Rössle, M....
Journal of Crohn's and Colitis Supplements.  1 (2007)  1 - p. 16 , 2007
 
?
9

P048 A CLINICAL TRIAL ON ABSORPTION AND N-ACETYLATION OF OR..:

Dilger, K. ; Trenk, D. ; Rössle, M....
Journal of Crohn's and Colitis Supplements.  1 (2007)  1 - p. 16 , 2007
 
?
10

A clinical trial on absorption and N‐acetylation of oral an..:

Dilger, K. ; Trenk, D. ; Rössle, M....
European Journal of Clinical Investigation.  37 (2007)  7 - p. 558-565 , 2007
 
?
11

583 POSTER mTORC1 inhibition with rapamycin leads to activa..:

Werzowa, J. ; Pratscher, B. ; Cejka, D...
European Journal of Cancer Supplements.  4 (2006)  12 - p. 176-177 , 2006
 
?
12

69 POSTER Therapeutic effect of everolimus (RAD001) in comb..:

Cejka, D. ; Preusser, M. ; Sieghart, W....
European Journal of Cancer Supplements.  4 (2006)  12 - p. 25 , 2006
 
?
13

69 POSTER Therapeutic effect of everolimus (RAD001) in comb..:

Cejka, D. ; Preusser, M. ; Sieghart, W....
European Journal of Cancer Supplements.  4 (2006)  12 - p. 25 , 2006
 
?
14

583 POSTER mTORC1 inhibition with rapamycin leads to activa..:

Werzowa, J. ; Pratscher, B. ; Cejka, D...
European Journal of Cancer Supplements.  4 (2006)  12 - p. 176-177 , 2006
 
1-15